Decreased Long Noncoding RNA SPRY4-IT1 Contributing to Gastric Cancer Cell Metastasis Partly Via Affecting Epithelial-mesenchymal Transition

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2015 Aug 5

PMID 26238992

Citations 53

Authors

Min Xie

Feng-Qi Nie

Ming Sun

Rui Xia

Yan-Wen Liu

Peng Zhou

Wei De

Xiang-Hua Liu

Affiliations

Soon will be listed here.

Abstract

Background: Long noncoding RNAs (lncRNAs) are emerging as key regulators governing fundamental biological processes, and their disorder expression involves in tumorigenesis. SPRY4-IT1 (SPRY4 intronic transcript 1), a lncRNA derived from an intron within SPRY4 gene, involves in multiple cancers development. However, the expression pattern and biological function of SPRY4-IT1 in gastric cancer is still not well documented. Hence, we carried out the present study to investigate the potential role of SPRY4-IT1 in gastric carcinogenesis.

Methods: QRT-PCR was performed to detect the expression of SPRY4-IT1 in 61 pairs of gastric cancer samples. Over-expression and RNA interference (RNAi) approaches were used to investigate the biological functions of SPRY4-IT1. The effect of SPRY4-IT1 on proliferation was evaluated by MTT and colony formation assays. Gastric cancer cells transfected with pCDNA-SPRY4-IT1 were injected into nude mice to study the effect of SPRY4-IT1 on tumorigenesis and metastasis in vivo. Protein levels of SPRY4-IT1 targets were determined by western blot or fluorescence immunohistochemistry. ChIP assays were performed to investigate the effect of DNMT1 on SPRY4-IT1 expression. Differences between groups were tested for significance using Student's t test (two-tailed).

Results: SPRY4-IT1 expression is decreased in gastric cancer tissues and associated with larger tumor size, advanced pathological stage, deeper depth of invasion and lymphatic metastasis. Patients with lower SPRY4-IT1 expression had a relatively poor prognosis. DNA methylation may be a key factor in controlling the SPRY4-IT1 expression. Furthermore, SPRY4-IT1 contributed to gastric cancer cells metastasis might partly via regulating epithelial-mesenchymal transition (EMT) process.

Conclusion: Low expression of SPRY4-IT1 is involved in progression and metastasis of gastric cancer and may represent a novel biomarker of poor prognosis in patients with gastric cancer.

Citing Articles

Model ensembling as a tool to form interpretable multi-omic predictors of cancer pharmacosensitivity.

De Landtsheer S, Badkas A, Kulms D, Sauter T Brief Bioinform. 2024; 25(6).

PMID: 39494610 PMC: 11532660. DOI: 10.1093/bib/bbae567.

The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function.

Heidari-Ezzati S, Moeinian P, Ahmadian-Nejad B, Maghbbouli F, Abbasi S, Zahedi M Front Cell Dev Biol. 2024; 12:1308730.

PMID: 38434620 PMC: 10906305. DOI: 10.3389/fcell.2024.1308730.

Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma.

Feng Y, Li B, Wang K, Li X, Zhang L, Dong X Front Mol Biosci. 2022; 9:977280.

PMID: 36310592 PMC: 9605205. DOI: 10.3389/fmolb.2022.977280.

Regulatory function of DNA methylation mediated lncRNAs in gastric cancer.

Li N, Zeng A, Wang Q, Chen M, Zhu S, Song L Cancer Cell Int. 2022; 22(1):227.

PMID: 35810299 PMC: 9270757. DOI: 10.1186/s12935-022-02648-1.

Role of different non-coding RNAs as ovarian cancer biomarkers.

Beg A, Parveen R, Fouad H, Yahia M, Hassanein A J Ovarian Res. 2022; 15(1):72.

PMID: 35715825 PMC: 9206245. DOI: 10.1186/s13048-022-01002-3.

References

Ali Z, Deng Y, Ma C . Progress of research in gastric cancer. J Nanosci Nanotechnol. 2013; 12(11):8241-8. DOI: 10.1166/jnn.2012.6692. View

Singh A, Settleman J . EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29(34):4741-51. PMC: 3176718. DOI: 10.1038/onc.2010.215. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

Rinn J, Chang H . Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012; 81:145-66. PMC: 3858397. DOI: 10.1146/annurev-biochem-051410-092902. View

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

Guttman M, Donaghey J, Carey B, Garber M, Grenier J, Munson G . lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011; 477(7364):295-300. PMC: 3175327. DOI: 10.1038/nature10398. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

Hung T, Wang Y, Lin M, Koegel A, Kotake Y, Grant G . Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011; 43(7):621-9. PMC: 3652667. DOI: 10.1038/ng.848. View

Khaitan D, Dinger M, Mazar J, Crawford J, Smith M, Mattick J . The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011; 71(11):3852-62. DOI: 10.1158/0008-5472.CAN-10-4460. View

10.

Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M . Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2010; 30(16):1956-62. PMC: 3230933. DOI: 10.1038/onc.2010.568. View

11.

Wang K, Yang Y, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y . A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011; 472(7341):120-4. PMC: 3670758. DOI: 10.1038/nature09819. View

12.

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

13.

Tsai M, Spitale R, Chang H . Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011; 71(1):3-7. PMC: 3057914. DOI: 10.1158/0008-5472.CAN-10-2483. View

14.

Loewer S, Cabili M, Guttman M, Loh Y, Thomas K, Park I . Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010; 42(12):1113-7. PMC: 3040650. DOI: 10.1038/ng.710. View

15.

Yang F, Huo X, Yuan S, Zhang L, Zhou W, Wang F . Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013; 49(6):1083-96. DOI: 10.1016/j.molcel.2013.01.010. View

16.

Karreth F, Pandolfi P . ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013; 3(10):1113-21. PMC: 3801300. DOI: 10.1158/2159-8290.CD-13-0202. View

17.

Zou Y, Jiang Z, Yu X, Sun M, Zhang Y, Zuo Q . Upregulation of long noncoding RNA SPRY4-IT1 modulates proliferation, migration, apoptosis, and network formation in trophoblast cells HTR-8SV/neo. PLoS One. 2013; 8(11):e79598. PMC: 3819274. DOI: 10.1371/journal.pone.0079598. View

18.

Sun M, Liu X, Wang K, Nie F, Kong R, Yang J . Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014; 13:68. PMC: 3998010. DOI: 10.1186/1476-4598-13-68. View

19.

Liu X, Sun M, Nie F, Ge Y, Zhang E, Yin D . Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014; 13:92. PMC: 4021402. DOI: 10.1186/1476-4598-13-92. View

20.

Sun M, Liu X, Lu K, Nie F, Xia R, Kong R . EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014; 5:e1298. PMC: 4611729. DOI: 10.1038/cddis.2014.256. View